Search

Author/Creator Pieczonka, C.

2. 2526 Immune responses and clinical data from STRIDE, a randomized, phase 2, open label study of sipuleucel-T with concurrent vs sequential enzalutamide administration in metastatic castrationresistant prostate cancer. (September 2015)

Authors:
Petrylak, D.; Quinn, D.; Dreicer, R.; Antonarakis, E.; Shore, N.; Corman, J.; Concepcion, R.; Pieczonka, C.; Chang, N.; DeVries, T.; Sheikh, N.; Drake, C.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S483
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search